BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18980971)

  • 1. SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2.
    O-charoenrat P; Sarkaria I; Talbot SG; Reddy P; Dao S; Ngai I; Shaha A; Kraus D; Shah J; Rusch V; Ramanathan Y; Singh B
    Clin Cancer Res; 2008 Nov; 14(21):6780-9. PubMed ID: 18980971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas.
    Sarkaria I; O-charoenrat P; Talbot SG; Reddy PG; Ngai I; Maghami E; Patel KN; Lee B; Yonekawa Y; Dudas M; Kaufman A; Ryan R; Ghossein R; Rao PH; Stoffel A; Ramanathan Y; Singh B
    Cancer Res; 2006 Oct; 66(19):9437-44. PubMed ID: 17018598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-associated (UBA) domain of SCCRO/DCUN1D1 protein serves as a feedback regulator of biochemical and oncogenic activity.
    Huang G; Towe CW; Choi L; Yonekawa Y; Bommeljé CC; Bains S; Rechler W; Hao B; Ramanathan Y; Singh B
    J Biol Chem; 2015 Jan; 290(1):296-309. PubMed ID: 25411243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of SCCRO (DCUN1D1) in prostate cancer and its proliferation-inhibiting effect on Lncap cells.
    Zhang ZH; Li J; Luo F; Wang YS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4283-4291. PubMed ID: 29077169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.
    Talbot SG; O-charoenrat P; Sarkaria IS; Ghossein R; Reddy P; Ngai I; Cordeiro CN; Wong RJ; Kris MG; Rusch VW; Singh B
    Ann Surg Oncol; 2004 May; 11(5):530-4. PubMed ID: 15123463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.
    Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B
    Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.
    Choi J; Choi K; Benveniste EN; Rho SB; Hong YS; Lee JH; Kim J; Park K
    Cancer Res; 2005 Jul; 65(13):5554-60. PubMed ID: 15994927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between matrix metalloproteinase 2 and lung cancer progression.
    Guo CB; Wang S; Deng C; Zhang DL; Wang FL; Jin XQ
    Mol Diagn Ther; 2007; 11(3):183-92. PubMed ID: 17570740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
    Mitra RS; Goto M; Lee JS; Maldonado D; Taylor JM; Pan Q; Carey TE; Bradford CR; Prince ME; Cordell KG; Kirkwood KL; D'Silva NJ
    Cancer Res; 2008 May; 68(10):3959-69. PubMed ID: 18483282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation.
    Chen H; Yuan Y; Zhang C; Luo A; Ding F; Ma J; Yang S; Tian Y; Tong T; Zhan Q; Liu Z
    J Biol Chem; 2012 May; 287(21):17109-17119. PubMed ID: 22451655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.
    Shuang Y; Li C; Zhou X; Huang Y; Zhang L
    Oncol Rep; 2017 Oct; 38(4):2155-2165. PubMed ID: 28791411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCCRO promotes glioma formation and malignant progression in mice.
    Broderick SR; Golas BJ; Pham D; Towe CW; Talbot SG; Kaufman A; Bains S; Huryn LA; Yonekawa Y; Carlson D; Hambardzumyan D; Ramanathan Y; Singh B
    Neoplasia; 2010 Jun; 12(6):476-84. PubMed ID: 20563250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.